Literature DB >> 9725513

Infrainguinal reconstructions: influence of surgical experience on outcome.

M Luther1, M Lepäntalo.   

Abstract

OBJECTIVES: To evaluate the influence of surgical experience and operation technique on the outcome of infrainguinal reconstructions.
DESIGN: A longitudinal observational study of patients undergoing reconstructions to the popliteal and crural arteries.
SETTING: A regional hospital and an academic referral centre. MATERIALS: 392 patients undergoing 442 reconstructions, 218 to the popliteal and 228 to the crural vessels. CHIEF OUTCOME MEASURES: Graft patency and leg salvage. MAIN
RESULTS: At the popliteal level, 5-year patency after autogenous vein reconstruction was 76%. No difference was found between in situ and transposed vein reconstructions, but prosthetic reconstructions had a worse patency. At the crural level, 5-year patency for in situ vein, transposed vein and prosthetic bypass were 66, 55 and 21%, respectively. Corresponding leg salvage for chronic critical leg ischaemia was 91% with vein and 55% with prosthetic reconstruction at popliteal level, and 66 and 33% at the crural level. Surgical experience improved the outcome, as 3-year patency for in situ and transposed vein bypasses to the popliteal level were 82 and 95% for experienced surgeons, and 53 and 75% for less experienced surgeons. Corresponding leg salvage rates for reconstructions to the popliteal and crural levels were 85 and 67% for experienced surgeons, and 61 and 52% for less experienced surgeons.
CONCLUSIONS: Outcome of infrainguinal reconstructions is influenced by the reconstruction level. Surgical experience and choice of the appropriate reconstruction technique can improve outcome.

Entities:  

Mesh:

Year:  1998        PMID: 9725513     DOI: 10.1016/s0967-2109(97)00171-3

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  1 in total

1.  Popliteal-to-distal artery bypass for diabetic limb salvage.

Authors:  A E Brannigan; K Ahmad; M Tubassum; M Clarke Moloney; P A Grace; P E Burke
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.